JPRN-jRCT2080221352未知3 期
Evaluation of the effect of FYX-051 on cardiac repolarization : a thorough QT/QTc study.
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 59age old（—）
- 性别
- All
入选标准
- •Japanese healthy adult subjects
- •Body weight:male 50kg or more, female 40kg or more
排除标准
- •Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study
研究者
相似试验
未知
3 期
ong-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221035SANWA KAGAKU KENKYUSHO Co., Ltd.
未知
3 期
ong-Term Safety and Efficacy of FYX-051 in Patients with Hyperuricemia (with or without Gout)JPRN-jRCT2080221050Fuji Yakuhin Co., Ltd.
未知
2 期
Exploratory study of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221278Fuji Yakuhin Co., Ltd.
未知
2 期
Clinical pharmacology study of FYX-051 for subjects with renal insufficiencySubjects with renal insufficiencyJPRN-jRCT2080221510Fuji Yakuhin Co., Ltd.
未知
2 期
Exploratory study 2 of FYX-051 in Patients with Hyperuricemia (with or without Gout)Hyperuricemia and GoutJPRN-jRCT2080221279Fuji Yakuhin Co., Ltd.